Cubist Pharmaceuticals

Cubist Pharmaceuticals

Research and development to commercialization of pharmaceutical products.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round

$9.5b

Acquisition
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by Cubist Pharmaceuticals

Edit
Optimer Pharmaceuticals
ACQUISITION by Cubist Pharmaceuticals Oct 2013
Trius Therapeutics
ACQUISITION by Cubist Pharmaceuticals Jul 2013
Adolor
ACQUISITION by Cubist Pharmaceuticals Dec 2011
Calixa Therapeutics
ACQUISITION by Cubist Pharmaceuticals Dec 2009